James Lee analyst MIZUHO

Currently out of the existing stock ratings of James Lee, 374 are a BUY (71.51%), 16 are a SELL (3.06%), 133 are a HOLD (25.43%).

James Lee

Work Performance Price Targets & Ratings Chart

Analyst James Lee, currently employed at MIZUHO, carries an average stock price target met ratio of 59.32% that have a potential upside of 38.35% achieved within 166 days.

James Lee’s has documented 1,045 price targets and ratings displayed on 47 stocks. The coverage is on Communication Services, Consumer Cyclical, Healthcare, Technology sectors.

Most recent stock forecast was given on AMZN, Amazon.com at 10-Dec-2024.

Wall Street Analyst James Lee

Analyst best performing recommendations are on CORT (CORCEPT THERAPEUTICS ORPORATED).
The best stock recommendation documented was for CORT (CORCEPT THERAPEUTICS ORPORATED) at 8/2/2023. The price target of $29 was fulfilled within 1 day with a profit of $3.99 (15.95%) receiving and performance score of 159.54.

Average potential price target upside

ABNB Airbnb  AMZN Amazon.com ARGX argenx NV ADR AXSM Axsome Therapeutics BABA Alibaba Group Holding Ltd BIDU Baidu BKNG Booking Holdings CNCE Concert Pharmaceuticals CPNG Coupang LLC DASH DoorDash . Common Stock EBAY eBay EXPE Expedia Group . FB Meta Platforms . GOOG Alphabet Class C GOOGL Alphabet JD JD.com Adr META Meta Platforms . SAGE Sage Therapeutic TCOM Trip.com Group Ltd ADR TRIP TripAdvisor TRVG Trivago NV TWTR Twitter UBER Uber Technologies A Agilent Technologies ADVM Adverum Biotechnologies ANAB AnaptysBio CPRX Catalyst Pharmaceuticals NTLA Intellia Therapeutics GBT Global Blood Therapeutics RARE Ultragenyx MRNS Marinus Pharmaceuticals WVE Wave Life Sciences Ltd CRMD CorMedix EDIT Editas Medicine APTX Aptinyx ARVN Arvinas CRSP Crispr Therapeutics AG CTRP Trip.com Group EBC Eastern Bankshares LJPC La Jolla Pharmaceutical Co PRFT Perficient RLMD Relmada Therapeutics TCEHY Tencent Holdings Ltd ADR TSHA Taysha Gene Therapies  VKTX Viking Therapeutics VRNA Verona Pharma PLC ADR CORT Corcept Therapeutics orporated

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$123

$-10.06 (-7.56%)

$140

16 days ago
(04-Dec-2024)

12/15 (80%)

$-14.34 (-10.44%)

119

Hold

$131

$-2.06 (-1.55%)

$145

1 months 2 days ago
(18-Nov-2024)

10/15 (66.67%)

$-1.05 (-0.80%)

110

Buy

$160

$26.94 (20.25%)

$130

1 months 9 days ago
(11-Nov-2024)

8/13 (61.54%)

$21.92 (15.87%)

176

Buy

$158

$24.94 (18.74%)

$167

1 months 9 days ago
(11-Nov-2024)

10/14 (71.43%)

$19.92 (14.43%)

196

Hold

$145

$11.94 (8.97%)

$125

1 months 12 days ago
(08-Nov-2024)

12/17 (70.59%)

$11.29 (8.44%)

37

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is James Lee is most bullish on?

Potential upside of $172.39 has been obtained for BKNG (BOOKING HOLDINGS)

Which stock is James Lee is most reserved on?

Potential downside of -$3.84 has been obtained for EBAY (EBAY)

What Year was the first public recommendation made by James Lee?

On 2013

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?